Skip to main content
Quest Diagnostics

Long Non-coding RNA Signatures to Distinguish Relapsing-Remitting and Progression Forms of Multiple Sclerosis

The European Committee for Treatment and Research in Multiple Sclerosis, 9th joint ECTRIMS-ACTRIMS meetings

ECTRIM 2023

Milan, Italy Oct 11-13, 2023

Poster presentation: Long Non-coding RNA Signatures to Distinguish Relapsing-Remitting and Progression Forms of Multiple Sclerosis

Authors: Sesler CL, Wylezinski LS, Shaginurova GI, Grigorenko EV, Cockerill, FR III, Racke MK, Spurlock, CF III

Specialty: Neurology

Reated content

Publication
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference Proceedings
Publication
COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
Publication
Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.